Recursion Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships?

In recent days, Recursion Pharmaceuticals announced a major leadership transition appointing Najat Khan, Ph.D., as CEO effective January 1, 2026, while also securing a milestone payment from Roche and ...

The hidden humans powering the AI economy

We usually hear two sides to the AI and employment story: star engineers earning enormous salaries, and job loss for many ...

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...

B.C. Hydro says it should have been more proactive as Site C costs ballooned to $16B

B.C. Hydro says in a "lessons learned report" to the British Columbia Utilities Commission that it's on track to complete the ...